share_log

亚太药业:北京国枫(杭州)律师事务所关于浙江亚太药业股份有限公司 2024 年第二次临时股东大会的法律意见书

Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng (Hangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.

SZSI ·  Dec 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more